Schedule 13G ownership disclosure
AVID BIOSERVICES INC
Common · CUSIP: 05368M106
Event date: 2024-12-31
- Filing-level shares
- 3,797,813.00
- Percent of class
- 5.9%
- AltraVue Capital, LLC
Shares: 3,797,813.00 · Class: 5.9%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001740837-25-000003
- Form type
- SCHEDULE 13G/A
- Filer
- AltraVue Capital, LLC
- CIK
- CIK 1740837
- Filed
- Jan 14, 2025
- Reporting period
- Dec 31, 2024
- Description
- Schedule 13G beneficial ownership